DK0697859T3 - Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH - Google Patents
Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPHInfo
- Publication number
- DK0697859T3 DK0697859T3 DK94914734.2T DK94914734T DK0697859T3 DK 0697859 T3 DK0697859 T3 DK 0697859T3 DK 94914734 T DK94914734 T DK 94914734T DK 0697859 T3 DK0697859 T3 DK 0697859T3
- Authority
- DK
- Denmark
- Prior art keywords
- nadph
- stable
- oral
- nadp
- therapeutic preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/055,049 US5332727A (en) | 1993-04-29 | 1993-04-29 | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0697859T3 true DK0697859T3 (da) | 1997-12-29 |
Family
ID=21995236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94914734.2T DK0697859T3 (da) | 1993-04-29 | 1994-03-25 | Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH |
Country Status (16)
Country | Link |
---|---|
US (1) | US5332727A (el) |
EP (1) | EP0697859B1 (el) |
JP (1) | JP3683582B2 (el) |
CN (1) | CN1072483C (el) |
AT (1) | ATE153853T1 (el) |
AU (1) | AU674583B2 (el) |
BR (1) | BR9406514A (el) |
CA (1) | CA2161641C (el) |
DE (1) | DE69403656T2 (el) |
DK (1) | DK0697859T3 (el) |
ES (1) | ES2103587T3 (el) |
GR (1) | GR3024561T3 (el) |
IL (1) | IL109186A (el) |
MX (1) | MX9402938A (el) |
TW (1) | TW336895B (el) |
WO (1) | WO1994025007A1 (el) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2167104A1 (en) * | 1995-01-17 | 1996-07-18 | Joerg G.D. Birkmayer | Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
US6340474B1 (en) | 1999-08-03 | 2002-01-22 | Charles A. Mesko | Composition for potentiating a growth hormone and a method for preparation of said composition |
IT1318565B1 (it) * | 2000-06-09 | 2003-08-27 | World Pharma Tech Ltd | Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e. |
AR029538A1 (es) | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
AR034813A1 (es) * | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
ITBO20020140A1 (it) * | 2002-03-21 | 2003-09-22 | Valpharma Sa | Formulazioni a base di nadh in forma di multiparticolato con rivestimento gastroresistente o a rilascio modificato |
AT502435B1 (de) * | 2002-11-19 | 2008-01-15 | Oekopharm Forschungs Und Entwi | Pharmazeutische zusammensetzung umfassend ein wasserstoffübertragendes coenzym und chlorophyll |
US7034011B2 (en) * | 2002-12-03 | 2006-04-25 | Kyowa Hakko Kogyo Co., Ltd. | Method of stabilizing reduced nicotinamide adenine dinucleotide or reduced nicotinamide adenine dinucleotide phosphate |
US20040126751A1 (en) * | 2002-12-27 | 2004-07-01 | Birkmayer Jorg G.D. | Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
US20050226923A1 (en) * | 2004-04-07 | 2005-10-13 | Gassert Chad M | Venlafaxine compositions in the form of microtablets |
PE20060167A1 (es) * | 2004-04-08 | 2006-04-20 | Wyeth Corp | Formulaciones de dispersion solida que comprende acetato de bazedoxifeno |
AU2005233128A1 (en) * | 2004-04-08 | 2005-10-27 | Wyeth | Bazedoxifene ascorbate as selective estrogen receptor modulator |
JPWO2006073162A1 (ja) * | 2005-01-07 | 2008-06-12 | 協和醗酵工業株式会社 | Nadhもしくはnadphまたはその塩の保存安定性向上方法 |
JPWO2006106805A1 (ja) * | 2005-03-30 | 2008-09-11 | 協和醗酵工業株式会社 | 物質の保存安定性向上方法 |
ITMI20060629A1 (it) | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
ITMI20071374A1 (it) | 2007-07-10 | 2009-01-11 | Gnosis Spa | Sali stabili di s-adenosilmetionina e processo per il loro ottenimento. |
US20100200237A1 (en) * | 2009-02-12 | 2010-08-12 | Colgate Sam O | Methods for controlling temperatures in the environments of gas and oil wells |
US20100236784A1 (en) * | 2009-03-20 | 2010-09-23 | Horton Robert L | Miscible stimulation and flooding of petroliferous formations utilizing viscosified oil-based fluids |
US20100252259A1 (en) * | 2009-04-01 | 2010-10-07 | Horton Robert L | Oil-based hydraulic fracturing fluids and breakers and methods of preparation and use |
US20100263867A1 (en) * | 2009-04-21 | 2010-10-21 | Horton Amy C | Utilizing electromagnetic radiation to activate filtercake breakers downhole |
DE102012104451A1 (de) * | 2012-05-23 | 2013-11-28 | Jürgen Ruhlmann | Komposition zur Behandlung einer Störung des circadianen Rhythmus |
EP3129060B1 (en) * | 2014-04-08 | 2018-04-25 | Dow Global Technologies LLC | Dispersion comprising an esterified cellulose ether |
RU2545920C1 (ru) * | 2014-04-23 | 2015-04-10 | Аллан Герович Бениашвили | Композиция nadh, обладающая антиоксидантными свойствами |
EP2944312B1 (de) | 2014-05-16 | 2022-01-26 | TP Tumapharma Ltd | Kombinationspräparat, umfassend glucosamin und chondroitinsulfat |
CN104840479A (zh) * | 2015-02-17 | 2015-08-19 | 苏州人本药业有限公司 | Nadph在制备治疗心脏疾病药物中的应用 |
CN104758307A (zh) * | 2015-03-16 | 2015-07-08 | 邦泰生物工程(深圳)有限公司 | Nadh和nmn在制备帕金森病药物或保健品的应用 |
WO2019028877A1 (zh) * | 2017-08-11 | 2019-02-14 | 邦泰生物工程(深圳)有限公司 | 一种含有nadh和nadph的组合物及其应用 |
CN109893510A (zh) * | 2019-02-28 | 2019-06-18 | 合肥康诺药物开发有限公司 | 一种辅酶i肠溶片及其制备方法 |
BR102020013862A2 (pt) * | 2020-07-07 | 2022-01-18 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson |
DE202022000567U1 (de) | 2022-03-06 | 2022-03-16 | Penta Phi Eg | Liposomale Formulierung |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1930059C3 (de) * | 1969-06-13 | 1975-11-13 | Boehringer Mannheim Gmbh | Stabilisiertes Nicotinamid-adenindinucleotid oder bzw. und Nicotinamld-adenin-dinucleotidphosphat |
GB1359643A (en) * | 1970-09-28 | 1974-07-10 | Controlled Medications | Controlled release medicament |
CA1187388A (en) * | 1978-09-20 | 1985-05-21 | American Monitor Corporation | Stabilization of working reagent solutions containing nadh, nadph, and/or enzymes, and the use of such stabilized reagents in enzymes or substrate assays |
JPS5748908A (en) * | 1980-09-08 | 1982-03-20 | Kyorin Pharmaceut Co Ltd | Prolonged release type nicomol pharmaceutical |
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
JPS6144811A (ja) * | 1984-08-10 | 1986-03-04 | Ss Pharmaceut Co Ltd | 徐放性ジクロフエナクナトリウム製剤 |
CA1336169C (en) * | 1988-03-01 | 1995-07-04 | Walther Birkmayer | Agent for treatment of parkinson's disease |
JPH01308231A (ja) * | 1988-06-03 | 1989-12-12 | Takeda Chem Ind Ltd | 安定化された医薬組成物および製造法 |
AT397201B (de) * | 1988-06-03 | 1994-02-25 | Birkmayer Joerg Ddr | Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels |
US5135757A (en) * | 1988-09-19 | 1992-08-04 | Edward Mendell Co., Inc. | Compressible sustained release solid dosage forms |
-
1993
- 1993-04-29 US US08/055,049 patent/US5332727A/en not_active Expired - Lifetime
-
1994
- 1994-03-25 DK DK94914734.2T patent/DK0697859T3/da active
- 1994-03-25 CA CA002161641A patent/CA2161641C/en not_active Expired - Lifetime
- 1994-03-25 AT AT94914734T patent/ATE153853T1/de active
- 1994-03-25 DE DE69403656T patent/DE69403656T2/de not_active Expired - Lifetime
- 1994-03-25 WO PCT/US1994/003290 patent/WO1994025007A1/en active IP Right Grant
- 1994-03-25 AU AU66980/94A patent/AU674583B2/en not_active Ceased
- 1994-03-25 CN CN94191939A patent/CN1072483C/zh not_active Expired - Fee Related
- 1994-03-25 EP EP94914734A patent/EP0697859B1/en not_active Expired - Lifetime
- 1994-03-25 ES ES94914734T patent/ES2103587T3/es not_active Expired - Lifetime
- 1994-03-25 JP JP52425894A patent/JP3683582B2/ja not_active Expired - Lifetime
- 1994-03-25 BR BR9406514A patent/BR9406514A/pt not_active Application Discontinuation
- 1994-03-31 IL IL10918694A patent/IL109186A/xx not_active IP Right Cessation
- 1994-04-22 MX MX9402938A patent/MX9402938A/es not_active IP Right Cessation
- 1994-04-29 TW TW083103881A patent/TW336895B/zh not_active IP Right Cessation
-
1997
- 1997-08-28 GR GR970402200T patent/GR3024561T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5332727A (en) | 1994-07-26 |
EP0697859B1 (en) | 1997-06-04 |
WO1994025007A1 (en) | 1994-11-10 |
TW336895B (en) | 1998-07-21 |
EP0697859A1 (en) | 1996-02-28 |
MX9402938A (es) | 1995-01-31 |
DE69403656D1 (de) | 1997-07-10 |
JP3683582B2 (ja) | 2005-08-17 |
IL109186A (en) | 2000-01-31 |
CN1121688A (zh) | 1996-05-01 |
ATE153853T1 (de) | 1997-06-15 |
IL109186A0 (en) | 1994-06-24 |
AU674583B2 (en) | 1997-01-02 |
DE69403656T2 (de) | 1997-10-16 |
JPH08512021A (ja) | 1996-12-17 |
BR9406514A (pt) | 1996-01-09 |
CA2161641A1 (en) | 1994-11-10 |
AU6698094A (en) | 1994-11-21 |
EP0697859A4 (en) | 1996-06-26 |
CA2161641C (en) | 1999-06-15 |
CN1072483C (zh) | 2001-10-10 |
ES2103587T3 (es) | 1997-09-16 |
GR3024561T3 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0697859T3 (da) | Stabile, orale og absorberbare terapeutiske præparater af NADP og NADPH | |
DE69701532T2 (de) | Orale zusammensetzung gegen zahnbelag | |
DK1213015T3 (da) | Oralt farmaceutisk præparat med forsinket frigivelse af protonpumpeinhibitorer | |
DK0841904T3 (da) | Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer | |
EP2261200A3 (en) | Modified forms of pharmacacologically active agents and uses therefor | |
AU7702291A (en) | Dietary fiber, its process and physiologically active composition containing the same as an active ingredient | |
NZ314442A (en) | Extended release formulation comprising venlafaxine hydrochloride, film coating composition | |
IS1812B (is) | Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra | |
TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
NO954878L (no) | Pyrrolderivater | |
IS4553A (is) | Lyfjablöndur sem innihalda mónóamín oxídasa B blokkara | |
PT615754E (pt) | Formas solidas de administracao oral de libertacao controlada flupertina | |
NO953763L (no) | Heterocykel-holdige amidin-derivater, deres fremstilling og anvendelse | |
AU4830097A (en) | Use of an extract of Cimicifuga | |
CA2328280A1 (en) | Thienopyrimidines | |
EP0345248A3 (de) | Verwendung des Enzym-Cofaktors NADPH zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung | |
TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
NO922842L (no) | Benzotiazolderivater, fremgangsmaate for deres fremstilling og deres anvendelse som terapeutika | |
DK1052991T3 (da) | Topisk anvendelse af loperamid til behandling af mikrobielle infektioner | |
DK1062954T3 (da) | Anvendelse af itakonsyre til regulering af det glykotiske stofskifte | |
NO895049L (no) | Fremgangsmaate for tilvirkning av polyorganosiloksan og ensammensetning som er utherdbar med straaling. | |
AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
ES2097181T3 (es) | Composicion antidepresiva a base de nicotinamida-adenina-dinucleotido. | |
PL327472A1 (en) | Nitrogen oxide (no) synthase inhibitor for use in treatment or polphylaxy of type ii diabetes | |
DK0791355T3 (da) | Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi |